Literature DB >> 678668

Nonreversible loss of platelet aggregability induced by calcium deprivation.

M B Zucker, R A Grant.   

Abstract

Platelets lose their ability to aggregate when deprived of divalent cations. This usually was studied by incubating human citrated platelet-rich plasma with EDTA or EGTA and then adding enough CaCl2 to combine with the chelating agent. Incubation for 5-7 min at 37 degrees C caused irreversible loss of the platelets' ability to adhere to glass and to aggregate with ADP, epinephrine, A23187, vasopressin, or serotonin or upon rewarming after chilling and markedly reduced aggregation with collagen or thrombin. Control samples incubated with saline, CaEDTA, or CaEGTA were not inhibited. Untreated platelets washed and incubated in solutions treated with resins that remove divalent cations lost their ability to aggregate in 30 min. More than about 0.26 mM Mg2+ partially protected the platelets. Unlike aggregation, ADP-induced shape change, clot retraction caused by thrombin or ADP plus reptilase, and thrombin-induced 14C-serotonin release were not inhibited after incubation. Aggregability was not restored by prolonged incubation with CaCl2, adding normal plasma, or washing the platelets. Its loss was temperature and pH dependent, occurring in 2 min at 43 degrees C but not in 7 min at 30 degrees C, and at pH 7.8 but much less at pH 7.2. The defect was not associated with an increase in platelet cyclic AMP, a decrease in metabolic ATP, or the presence of free ADP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 678668

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists.

Authors:  S S Rebello; J Huang; J D Faul; B R Lucchesi
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

Review 2.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

3.  Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.

Authors:  J A Ware; P C Johnson; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducible.

Authors:  Hina Zafar; Yi Shang; Jihong Li; George A David; Joseph P Fernandez; Henrik Molina; Marta Filizola; Barry S Coller
Journal:  Blood Adv       Date:  2017-02-22

5.  Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.

Authors:  L F Brass; S J Shattil
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  Studies of platelets with heavy metal impregnation techniques.

Authors:  R Yarom; R More; Y Havivi; G Lijovetzky; S Meyer
Journal:  Histochem J       Date:  1982-01

7.  The peptide LSARLAF causes platelet secretion and aggregation by directly activating the integrin alphaIIbbeta3.

Authors:  J M Derrick; D B Taylor; R G Loudon; T K Gartner
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

8.  Calcium and temperature regulation of the stability of the human platelet integrin GPIIb/IIIa in solution: an analytical ultracentrifugation study.

Authors:  G A Rivas; P Usobiaga; J González-Rodriguez
Journal:  Eur Biophys J       Date:  1991       Impact factor: 1.733

9.  Use of theophylline in the investigation of pseudothrombocytopenia induced by edetic acid (EDTA-2K).

Authors:  O Ohnuma; Y Shirata; K Miyazawa
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

10.  Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.

Authors:  W Siess; E G Lapetina
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.